Evidence map›Paper›PMID 42331677›Full record

ArticleThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry2026

Loneliness and Plasma Biomarkers of Neurodegeneration in Community-Dwelling Older Adults: Cross-Sectional and Longitudinal Analyses.

Ariel Gildengers, Yueting Wang, Tiffany F Hughes, Erin Jacobsen, Thomas K Karikari, Beth Snitz, Xuemei Zeng, Chung-Chou H Chang, Mary Ganguli

Abstract read
In one paragraph

Article in The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ariel GildengersDepartment of Psychiatry (AG, EJ, TKK, XZ, MG), University of Pittsburgh School of Medicine, Pittsburgh, PA. Electronic address: ariel.gildengers@pitt.edu.
Yueting WangDepartment of Biostatistics (YW, CCHC), University of Pittsburgh School of Public Health, Pittsburgh, PA.
Tiffany F HughesPublic Health Program (TFH), Midwestern University, Glendale, AZ.
Erin JacobsenDepartment of Psychiatry (AG, EJ, TKK, XZ, MG), University of Pittsburgh School of Medicine, Pittsburgh, PA.
Thomas K KarikariDepartment of Psychiatry (AG, EJ, TKK, XZ, MG), University of Pittsburgh School of Medicine, Pittsburgh, PA.
Beth SnitzDepartment of Neurology (BS, MG), University of Pittsburgh School of Medicine, Pittsburgh, PA.
Xuemei ZengDepartment of Psychiatry (AG, EJ, TKK, XZ, MG), University of Pittsburgh School of Medicine, Pittsburgh, PA.
Chung-Chou H ChangDepartment of Biostatistics (YW, CCHC), University of Pittsburgh School of Public Health, Pittsburgh, PA; Department of Medicine (CCHC), University of Pittsburgh School of Medicine, Pittsburgh, PA.
Mary GanguliDepartment of Psychiatry (AG, EJ, TKK, XZ, MG), University of Pittsburgh School of Medicine, Pittsburgh, PA; Department of Neurology (BS, MG), University of Pittsburgh School of Medicine, Pittsburgh, PA; Department of Epidemiology (MG), University of Pittsburgh School of Public Health, Pittsburgh, PA.

Funding

Vascular Moderators of the Impact of Alzheimer's Pathology in the Young-OldP01AG025204 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOWARD J AIZENSTEIN, Ann D. Cohen · 2005 to 2026
$56.5M
Longitudinal multicenter head-to-head harmonization of tau PET tracersR01AG073267 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAKER, SUZANNE L, PASCOAL, THARICK · 2021 to 2025
$41.1M
Research Education ComponentP30AG066468 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI C. Elizabeth Shaaban · 2020 to 2026
$29.4M
Mild Cognitive Impairment: A Prospective Community StudyR37AG023651 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Carmen Andreescu, MARY GANGULI · 2021 to 2026
$18.2M
Plasma brain-derived tau: a novel Alzheimer’s disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in bloodR01AG083874 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Thomas K Karikari · 2023 to 2026
$14.5M
The RAW Brain - The Effect of Rumination, Anxiety and Worry on Aging and Dementia RiskR01MH108509 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Carmen Andreescu · 2016 to 2026
$10.6M
Predictors of Altered CNS Structure, Function, and Connectomics in the Elderly using a Health Disparities FrameworkR01AG072641 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Ann D. Cohen · 2022 to 2026
$9.6M
Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC NetworkU24AG082930 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Nicole R. Fowler, Thomas K Karikari · 2023 to 2026
$7.3M
Examining the Persistence of Neurocognitive Benefits of ExerciseR01AG083156 · NIA · ADVENTHEALTH ORLANDO · PI ERICKSON, KIRK I · 2023 to 2025
$6.8M
Analytical characterization and validation of blood-biomarkers for monitoring TBI evolutionU01NS131740 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Ramon Diaz-Arrastia, Ava M. Puccio · 2024 to 2026
$4.7M
Roles of Gray Matter Brain Aging and Small Vessel Disease in AD PathophysiologyR01AG025516 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOWARD J AIZENSTEIN, Victor Luis Villemagne · 2024 to 2026
$4.4M
Head-to-head comparisons of high-performance plasma phospho-tau epitopes for the detection of Alzheimer's diseaseR01AG075336 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Tharick Pascoal · 2022 to 2026
$3.7M
NIA NIH HHS P01 AG025204NIA NIH HHS P30 AG066468NIA NIH HHS R01 AG025516NIA NIH HHS R01 AG072641NIA NIH HHS R01 AG073267NIA NIH HHS R01 AG075336NIA NIH HHS R01 AG083156NIA NIH HHS R01 AG083874NIA NIH HHS R37 AG023651NIA NIH HHS RF1 AG077474NIA NIH HHS U24 AG082930NIMH NIH HHS R01 MH108509NINDS NIH HHS U01 NS131740NINDS NIH HHS U01 NS141777
6 · The paper itself

Abstract

BACKGROUND/

objectiveLoneliness has been linked with cognitive decline and dementia. Studies show relationships between loneliness and neurodegeneration, amyloid, and tau burden. We investigated whether loneliness relates to plasma biomarkers of neurodegenerative processes among cognitively normal or mildly impaired older adults at the population level. SETTING/

participantsA population-based cohort (n = 884) in southwestern Pennsylvania. MEASUREMENTS: Demographics; loneliness and social isolation composite scores, depression symptoms, Clinical Dementia Rating, plasma amyloid beta (Aβ) 42, Aβ40, p-tau181, p-tau217, NfL, GFAP.

designWe examined the associations of loneliness with plasma biomarkers using regression analyses in both cross-sectional and longitudinal models. For cross-sectional analysis, we used data from 884 dementia-free participants at the closest wave to biomarker testing (within 180 days). For longitudinal analysis, we first derived loneliness trajectories from 514 participants with repeated annual loneliness measurements for up to 15 years prior to biomarker testing, then used these trajectories as predictors in regression models examining their associations with plasma biomarkers.

resultsCompared with the stable loneliness trajectory, the increasing loneliness trajectory showed nominally higher p-tau181 levels (β = 0.305 log-transformed, 95% CI: 0.022, 0.587; t_476 = 2.112; p = 0.035, uncorrected; multiple comparison-adjusted p = 0.211), adjusting for age, sex, education, social isolation, and depression symptoms.

conclusionsThis exploratory analysis found a nominal association between increasing loneliness and p-tau181 that did not survive correction for multiple comparisons. Findings should be considered hypothesis-generating. If confirmed through replication in larger samples, associations between loneliness patterns and tau pathology could inform understanding of psychosocial contributions to neurodegeneration.

Indexed as

Amyloid beta-PeptidesCognitive DysfunctionLonelinessNeurofilament ProteinsPeptide Fragmentstau ProteinsAgedAged, 80 and overBiomarkersCross-Sectional StudiesDepressionFemaleHumansIndependent LivingLongitudinal StudiesMaleAmyloid beta-Peptidesamyloid beta-protein (1-40)amyloid beta-protein (1-42)Biomarkersneurofilament protein LNeurofilament ProteinsPeptide Fragmentstau ProteinsAlzheimer’s diseaseLonelinessmild cognitive impairmentplasma biomarkers

Identifiers

PMID42331677
PMCPMC13632764

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.